Logo image of SYK

STRYKER CORP (SYK) Stock Fundamental Analysis

NYSE:SYK - New York Stock Exchange, Inc. - US8636671013 - Common Stock - Currency: USD

382.35  +1.96 (+0.52%)

After market: 382.35 0 (0%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to SYK. SYK was compared to 188 industry peers in the Health Care Equipment & Supplies industry. SYK scores excellent on profitability, but there are some minor concerns on its financial health. SYK has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year SYK was profitable.
SYK had a positive operating cash flow in the past year.
Each year in the past 5 years SYK has been profitable.
Each year in the past 5 years SYK had a positive operating cash flow.
SYK Yearly Net Income VS EBIT VS OCF VS FCFSYK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

1.2 Ratios

SYK has a better Return On Assets (6.21%) than 87.77% of its industry peers.
With an excellent Return On Equity value of 13.66%, SYK belongs to the best of the industry, outperforming 90.96% of the companies in the same industry.
SYK has a better Return On Invested Capital (11.71%) than 94.15% of its industry peers.
The Average Return On Invested Capital over the past 3 years for SYK is above the industry average of 7.71%.
The 3 year average ROIC (11.52%) for SYK is below the current ROIC(11.71%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.21%
ROE 13.66%
ROIC 11.71%
ROA(3y)7.1%
ROA(5y)6.34%
ROE(3y)15.24%
ROE(5y)14.27%
ROIC(3y)11.52%
ROIC(5y)10.64%
SYK Yearly ROA, ROE, ROICSYK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

SYK's Profit Margin of 12.31% is amongst the best of the industry. SYK outperforms 90.43% of its industry peers.
In the last couple of years the Profit Margin of SYK has remained more or less at the same level.
SYK's Operating Margin of 22.35% is amongst the best of the industry. SYK outperforms 93.62% of its industry peers.
In the last couple of years the Operating Margin of SYK has remained more or less at the same level.
With a decent Gross Margin value of 64.57%, SYK is doing good in the industry, outperforming 67.02% of the companies in the same industry.
In the last couple of years the Gross Margin of SYK has remained more or less at the same level.
Industry RankSector Rank
OM 22.35%
PM (TTM) 12.31%
GM 64.57%
OM growth 3Y2.95%
OM growth 5Y-0.35%
PM growth 3Y4.36%
PM growth 5Y-1.09%
GM growth 3Y-0.02%
GM growth 5Y-0.49%
SYK Yearly Profit, Operating, Gross MarginsSYK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

4

2. Health

2.1 Basic Checks

SYK has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for SYK has been increased compared to 1 year ago.
Compared to 5 years ago, SYK has more shares outstanding
The debt/assets ratio for SYK has been reduced compared to a year ago.
SYK Yearly Shares OutstandingSYK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
SYK Yearly Total Debt VS Total AssetsSYK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.2 Solvency

An Altman-Z score of 5.08 indicates that SYK is not in any danger for bankruptcy at the moment.
SYK has a Altman-Z score of 5.08. This is in the better half of the industry: SYK outperforms 77.66% of its industry peers.
SYK has a debt to FCF ratio of 4.69. This is a neutral value as SYK would need 4.69 years to pay back of all of its debts.
SYK's Debt to FCF ratio of 4.69 is amongst the best of the industry. SYK outperforms 81.91% of its industry peers.
A Debt/Equity ratio of 0.69 indicates that SYK is somewhat dependend on debt financing.
SYK's Debt to Equity ratio of 0.69 is on the low side compared to the rest of the industry. SYK is outperformed by 68.09% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF 4.69
Altman-Z 5.08
ROIC/WACC1.37
WACC8.56%
SYK Yearly LT Debt VS Equity VS FCFSYK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.3 Liquidity

A Current Ratio of 1.64 indicates that SYK should not have too much problems paying its short term obligations.
With a Current ratio value of 1.64, SYK is not doing good in the industry: 73.40% of the companies in the same industry are doing better.
SYK has a Quick Ratio of 1.64. This is a bad value and indicates that SYK is not financially healthy enough and could expect problems in meeting its short term obligations.
SYK has a worse Quick ratio (1.00) than 76.60% of its industry peers.
Industry RankSector Rank
Current Ratio 1.64
Quick Ratio 1
SYK Yearly Current Assets VS Current LiabilitesSYK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

6

3. Growth

3.1 Past

SYK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.32%, which is quite good.
The Earnings Per Share has been growing by 8.09% on average over the past years. This is quite good.
SYK shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.76%.
The Revenue has been growing by 8.71% on average over the past years. This is quite good.
EPS 1Y (TTM)14.32%
EPS 3Y10.28%
EPS 5Y8.09%
EPS Q2Q%13.6%
Revenue 1Y (TTM)10.76%
Revenue growth 3Y9.72%
Revenue growth 5Y8.71%
Sales Q2Q%11.88%

3.2 Future

The Earnings Per Share is expected to grow by 9.92% on average over the next years. This is quite good.
Based on estimates for the next years, SYK will show a small growth in Revenue. The Revenue will grow by 7.76% on average per year.
EPS Next Y10.54%
EPS Next 2Y10.75%
EPS Next 3Y11.07%
EPS Next 5Y9.92%
Revenue Next Year9.63%
Revenue Next 2Y8.98%
Revenue Next 3Y8.77%
Revenue Next 5Y7.76%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
SYK Yearly Revenue VS EstimatesSYK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10B 20B 30B
SYK Yearly EPS VS EstimatesSYK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15 20

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 30.51 indicates a quite expensive valuation of SYK.
Based on the Price/Earnings ratio, SYK is valued a bit cheaper than 73.40% of the companies in the same industry.
SYK is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.19, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 25.57 indicates a quite expensive valuation of SYK.
Based on the Price/Forward Earnings ratio, SYK is valued a bit cheaper than the industry average as 71.81% of the companies are valued more expensively.
SYK is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.13, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 30.51
Fwd PE 25.57
SYK Price Earnings VS Forward Price EarningsSYK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SYK indicates a somewhat cheap valuation: SYK is cheaper than 71.81% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, SYK is valued a bit cheaper than the industry average as 77.13% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 40.85
EV/EBITDA 25.66
SYK Per share dataSYK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
SYK has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.89
PEG (5Y)3.77
EPS Next 2Y10.75%
EPS Next 3Y11.07%

6

5. Dividend

5.1 Amount

With a yearly dividend of 0.88%, SYK is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 1.86, SYK pays a better dividend. On top of this SYK pays more dividend than 92.02% of the companies listed in the same industry.
With a Dividend Yield of 0.88, SYK pays less dividend than the S&P500 average, which is at 2.40.
Industry RankSector Rank
Dividend Yield 0.88%

5.2 History

On average, the dividend of SYK grows each year by 9.04%, which is quite nice.
SYK has paid a dividend for at least 10 years, which is a reliable track record.
SYK has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)9.04%
Div Incr Years14
Div Non Decr Years14
SYK Yearly Dividends per shareSYK Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

SYK pays out 43.20% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of SYK is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP43.2%
EPS Next 2Y10.75%
EPS Next 3Y11.07%
SYK Yearly Income VS Free CF VS DividendSYK Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
SYK Dividend Payout.SYK Dividend Payout, showing the Payout Ratio.SYK Dividend Payout.PayoutRetained Earnings

STRYKER CORP

NYSE:SYK (5/29/2025, 8:16:01 PM)

After market: 382.35 0 (0%)

382.35

+1.96 (+0.52%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-01 2025-05-01/amc
Earnings (Next)07-28 2025-07-28/amc
Inst Owners79.74%
Inst Owner Change2.01%
Ins Owners0.1%
Ins Owner Change4.36%
Market Cap146.12B
Analysts80
Price Target437.4 (14.4%)
Short Float %1.59%
Short Ratio3.27
Dividend
Industry RankSector Rank
Dividend Yield 0.88%
Yearly Dividend3.2
Dividend Growth(5Y)9.04%
DP43.2%
Div Incr Years14
Div Non Decr Years14
Ex-Date06-30 2025-06-30 (0.84)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.36%
Min EPS beat(2)2.54%
Max EPS beat(2)4.19%
EPS beat(4)3
Avg EPS beat(4)2.25%
Min EPS beat(4)-0.26%
Max EPS beat(4)4.19%
EPS beat(8)7
Avg EPS beat(8)3.09%
EPS beat(12)9
Avg EPS beat(12)2.27%
EPS beat(16)11
Avg EPS beat(16)1.63%
Revenue beat(2)2
Avg Revenue beat(2)1%
Min Revenue beat(2)0.17%
Max Revenue beat(2)1.82%
Revenue beat(4)3
Avg Revenue beat(4)0.63%
Min Revenue beat(4)-0.7%
Max Revenue beat(4)1.82%
Revenue beat(8)6
Avg Revenue beat(8)1.19%
Revenue beat(12)8
Avg Revenue beat(12)1.23%
Revenue beat(16)11
Avg Revenue beat(16)1%
PT rev (1m)-0.01%
PT rev (3m)0.01%
EPS NQ rev (1m)-1.63%
EPS NQ rev (3m)-3.39%
EPS NY rev (1m)-0.13%
EPS NY rev (3m)-1.48%
Revenue NQ rev (1m)-0.96%
Revenue NQ rev (3m)0.5%
Revenue NY rev (1m)0.84%
Revenue NY rev (3m)1.28%
Valuation
Industry RankSector Rank
PE 30.51
Fwd PE 25.57
P/S 6.29
P/FCF 40.85
P/OCF 34.08
P/B 6.98
P/tB N/A
EV/EBITDA 25.66
EPS(TTM)12.53
EY3.28%
EPS(NY)14.95
Fwd EY3.91%
FCF(TTM)9.36
FCFY2.45%
OCF(TTM)11.22
OCFY2.93%
SpS60.75
BVpS54.77
TBVpS-11.23
PEG (NY)2.89
PEG (5Y)3.77
Profitability
Industry RankSector Rank
ROA 6.21%
ROE 13.66%
ROCE 13.63%
ROIC 11.71%
ROICexc 12.51%
ROICexgc 42.69%
OM 22.35%
PM (TTM) 12.31%
GM 64.57%
FCFM 15.41%
ROA(3y)7.1%
ROA(5y)6.34%
ROE(3y)15.24%
ROE(5y)14.27%
ROIC(3y)11.52%
ROIC(5y)10.64%
ROICexc(3y)12.76%
ROICexc(5y)11.81%
ROICexgc(3y)39.42%
ROICexgc(5y)36.5%
ROCE(3y)13.4%
ROCE(5y)12.38%
ROICexcg growth 3Y8.12%
ROICexcg growth 5Y2.5%
ROICexc growth 3Y8.12%
ROICexc growth 5Y0.63%
OM growth 3Y2.95%
OM growth 5Y-0.35%
PM growth 3Y4.36%
PM growth 5Y-1.09%
GM growth 3Y-0.02%
GM growth 5Y-0.49%
F-Score4
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF 4.69
Debt/EBITDA 2.3
Cap/Depr 66.95%
Cap/Sales 3.06%
Interest Coverage 250
Cash Conversion 68.59%
Profit Quality 125.11%
Current Ratio 1.64
Quick Ratio 1
Altman-Z 5.08
F-Score4
WACC8.56%
ROIC/WACC1.37
Cap/Depr(3y)62.25%
Cap/Depr(5y)59.95%
Cap/Sales(3y)3.11%
Cap/Sales(5y)3.16%
Profit Quality(3y)100.64%
Profit Quality(5y)122.75%
High Growth Momentum
Growth
EPS 1Y (TTM)14.32%
EPS 3Y10.28%
EPS 5Y8.09%
EPS Q2Q%13.6%
EPS Next Y10.54%
EPS Next 2Y10.75%
EPS Next 3Y11.07%
EPS Next 5Y9.92%
Revenue 1Y (TTM)10.76%
Revenue growth 3Y9.72%
Revenue growth 5Y8.71%
Sales Q2Q%11.88%
Revenue Next Year9.63%
Revenue Next 2Y8.98%
Revenue Next 3Y8.77%
Revenue Next 5Y7.76%
EBIT growth 1Y14.65%
EBIT growth 3Y12.96%
EBIT growth 5Y8.33%
EBIT Next Year25.23%
EBIT Next 3Y14.78%
EBIT Next 5Y11.56%
FCF growth 1Y57.79%
FCF growth 3Y8.39%
FCF growth 5Y17.73%
OCF growth 1Y49.62%
OCF growth 3Y9.14%
OCF growth 5Y14.13%